Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.

Nature communications

Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Liu F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram MA, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW, Kayser M, Hunter DJ, Newton Bishop JA, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martin NG.
PMID: 30643134
Nat Commun. 2019 Jan 14;10(1):299. doi: 10.1038/s41467-018-08078-w.

The original version of this Article contained errors in the spelling of the authors Fan Liu and M. Arfan Ikram, which were incorrectly given as Fan Lui and Arfan M. Ikram. In addition, the original version of this Article...

Cite
Duffy DL, Zhu G, Li X, et al. Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nat Commun. 2019;10(1):299doi: 10.1038/s41467-018-08078-w.
Duffy, D. L., Zhu, G., Li, X., Sanna, M., Iles, M. M., Jacobs, L. C., Evans, D. M., Yazar, S., Beesley, J., Law, M. H., Kraft, P., Visconti, A., Taylor, J. C., Liu, F., Wright, M. J., Henders, A. K., Bowdler, L., Glass, D., Ikram, M. A., Uitterlinden, A. G., Madden, P. A., Heath, A. C., Nelson, E. C., Green, A. C., Chanock, S., Barrett, J. H., Brown, M. A., Hayward, N. K., MacGregor, S., Sturm, R. A., Hewitt, A. W., Kayser, M., Hunter, D. J., Newton Bishop, J. A., Spector, T. D., Montgomery, G. W., Mackey, D. A., Smith, G. D., Nijsten, T. E., Bishop, D. T., Bataille, V., Falchi, M., Han, J., & Martin, N. G. (2019). Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nature communications, 10(1), 299. https://doi.org/10.1038/s41467-018-08078-w
Duffy, David L, et al. "Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways." Nature communications vol. 10,1 (2019): 299. doi: https://doi.org/10.1038/s41467-018-08078-w
Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Liu F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram MA, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW, Kayser M, Hunter DJ, Newton Bishop JA, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martin NG. Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nat Commun. 2019 Jan 14;10(1):299. doi: 10.1038/s41467-018-08078-w. PMID: 30643134; PMCID: PMC6331636.
Copy Download .nbib Format: NLM
[No title available]

Cancer management and research

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S.
PMID: 29795986
Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018.

PURPOSE: Melanoma represents an important public health problem, due to its high case-fatality rate. Identification of individuals at high risk would be of major interest to improve early diagnosis and ultimately survival. The aim of this study was to...

Cite
Tagliabue E, Gandini S, Bellocco R, et al. . Cancer Manag Res. 2018;10:1143-1154doi: 10.2147/CMAR.S155283.
Tagliabue, E., Gandini, S., Bellocco, R., Maisonneuve, P., Newton-Bishop, J., Polsky, D., Lazovich, D., Kanetsky, P. A., Ghiorzo, P., Gruis, N. A., Landi, M. T., Menin, C., Fargnoli, M. C., García-Borrón, J. C., Han, J., Little, J., Sera, F., & Raimondi, S. (2018). . Cancer management and research, 101143-1154. https://doi.org/10.2147/CMAR.S155283
Tagliabue, Elena, et al. "." Cancer management and research vol. 10 (2018): 1143-1154. doi: https://doi.org/10.2147/CMAR.S155283
Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S. . Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018. PMID: 29795986; PMCID: PMC5958947.
Copy Download .nbib Format: NLM
Reply to E. Hindié.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Maurichi A, Miceli R, Eriksson H, Newton-Bishop J, Nsengimana J, Chan M, Hayes AJ, Heelan K, Adams D, Patuzzo R, Barretta F, Gallino G, Harwood C, Bergamaschi D, Bennett D, Lasithiotakis K, Ghiorzo P, Dalmasso B, Manganoni A, Consoli F, Mattavelli I, Barbieri C, Leva A, Cortinovis U, Espeli V, Mangas C, Quaglino P, Ribero S, Broganelli P, Pellacani G, Longo C, Del Forno C, Borgognoni L, Sestini S, Pimpinelli N, Fortunato S, Chiarugi A, Nardini P, Morittu E, Florita A, Cossa M, Valeri B, Milione M, Pruneri G, Zoras O, Anichini A, Mortarini R, Santinami M.
PMID: 32701413
J Clin Oncol. 2020 Sep 20;38(27):3238-3240. doi: 10.1200/JCO.20.01460. Epub 2020 Jul 23.

No abstract available.

Cite
Maurichi A, Miceli R, Eriksson H, et al. Reply to E. Hindié. J Clin Oncol. 2020;38(27):3238-3240doi: 10.1200/JCO.20.01460.
Maurichi, A., Miceli, R., Eriksson, H., Newton-Bishop, J., Nsengimana, J., Chan, M., Hayes, A. J., Heelan, K., Adams, D., Patuzzo, R., Barretta, F., Gallino, G., Harwood, C., Bergamaschi, D., Bennett, D., Lasithiotakis, K., Ghiorzo, P., Dalmasso, B., Manganoni, A., Consoli, F., Mattavelli, I., Barbieri, C., Leva, A., Cortinovis, U., Espeli, V., Mangas, C., Quaglino, P., Ribero, S., Broganelli, P., Pellacani, G., Longo, C., Del Forno, C., Borgognoni, L., Sestini, S., Pimpinelli, N., Fortunato, S., Chiarugi, A., Nardini, P., Morittu, E., Florita, A., Cossa, M., Valeri, B., Milione, M., Pruneri, G., Zoras, O., Anichini, A., Mortarini, R., & Santinami, M. (2020). Reply to E. Hindié. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(27), 3238-3240. https://doi.org/10.1200/JCO.20.01460
Maurichi, Andrea, et al. "Reply to E. Hindié." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38,27 (2020): 3238-3240. doi: https://doi.org/10.1200/JCO.20.01460
Maurichi A, Miceli R, Eriksson H, Newton-Bishop J, Nsengimana J, Chan M, Hayes AJ, Heelan K, Adams D, Patuzzo R, Barretta F, Gallino G, Harwood C, Bergamaschi D, Bennett D, Lasithiotakis K, Ghiorzo P, Dalmasso B, Manganoni A, Consoli F, Mattavelli I, Barbieri C, Leva A, Cortinovis U, Espeli V, Mangas C, Quaglino P, Ribero S, Broganelli P, Pellacani G, Longo C, Del Forno C, Borgognoni L, Sestini S, Pimpinelli N, Fortunato S, Chiarugi A, Nardini P, Morittu E, Florita A, Cossa M, Valeri B, Milione M, Pruneri G, Zoras O, Anichini A, Mortarini R, Santinami M. Reply to E. Hindié. J Clin Oncol. 2020 Sep 20;38(27):3238-3240. doi: 10.1200/JCO.20.01460. Epub 2020 Jul 23. PMID: 32701413; PMCID: PMC7499609.
Copy Download .nbib Format: NLM
Correction to: Overlapping genetic architecture between Parkinson disease and melanoma.

Acta neuropathologica

Dube U, Ibanez L, Budde JP, Benitez BA, Davis AA, Harari O, Iles MM, Law MH, Brown KM, Cruchaga C.
PMID: 32172342
Acta Neuropathol. 2020 May;139(5):963. doi: 10.1007/s00401-020-02143-9.

The original version of this article unfortunately contained a mistake. Supplementary Tables 3 and 4 are not available with the rest of the supplementary material available online.

Cite
Dube U, Ibanez L, Budde JP, et al. Correction to: Overlapping genetic architecture between Parkinson disease and melanoma. Acta Neuropathol. 2020;139(5):963doi: 10.1007/s00401-020-02143-9.
Dube, U., Ibanez, L., Budde, J. P., Benitez, B. A., Davis, A. A., Harari, O., Iles, M. M., Law, M. H., Brown, K. M., & Cruchaga, C. (2020). Correction to: Overlapping genetic architecture between Parkinson disease and melanoma. Acta neuropathologica, 139(5), 963. https://doi.org/10.1007/s00401-020-02143-9
Dube, Umber, et al. "Correction to: Overlapping genetic architecture between Parkinson disease and melanoma." Acta neuropathologica vol. 139,5 (2020): 963. doi: https://doi.org/10.1007/s00401-020-02143-9
Dube U, Ibanez L, Budde JP, Benitez BA, Davis AA, Harari O, Iles MM, Law MH, Brown KM, Cruchaga C. Correction to: Overlapping genetic architecture between Parkinson disease and melanoma. Acta Neuropathol. 2020 May;139(5):963. doi: 10.1007/s00401-020-02143-9. PMID: 32172342.
Copy Download .nbib Format: NLM
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.

Cancers

Emran AA, Nsengimana J, Punnia-Moorthy G, Schmitz U, Gallagher SJ, Newton-Bishop J, Tiffen JC, Hersey P.
PMID: 32731355
Cancers (Basel). 2020 Jul 28;12(8). doi: 10.3390/cancers12082082.

BACKGROUND: Survival from melanoma is strongly related to patient sex, with females having a survival rate almost twice that of males. Many explanations have been proposed but have not withstood critical scrutiny. Prior analysis of different cancers with a...

Cite
Emran AA, Nsengimana J, Punnia-Moorthy G, et al. Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers (Basel). 2020;12(8)doi: 10.3390/cancers12082082.
Emran, A. A., Nsengimana, J., Punnia-Moorthy, G., Schmitz, U., Gallagher, S. J., Newton-Bishop, J., Tiffen, J. C., & Hersey, P. (2020). Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers, 12(8), . https://doi.org/10.3390/cancers12082082
Emran, Abdullah Al, et al. "Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts." Cancers vol. 12,8 (2020). doi: https://doi.org/10.3390/cancers12082082
Emran AA, Nsengimana J, Punnia-Moorthy G, Schmitz U, Gallagher SJ, Newton-Bishop J, Tiffen JC, Hersey P. Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers (Basel). 2020 Jul 28;12(8). doi: 10.3390/cancers12082082. PMID: 32731355; PMCID: PMC7464825.
Copy Download .nbib Format: NLM
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.

ESMO open

Lindsay CR, Shaw EC, Blackhall F, Blyth KG, Brenton JD, Chaturvedi A, Clarke N, Dick C, Evans TRJ, Hall G, Hanby AM, Harrison DJ, Johnston SRD, Mason MD, Morton D, Newton-Bishop J, Nicholson AG, Oien KA, Popat S, Rassl D, Sharpe R, Taniere P, Walker I, Wallace WA, West NP, Butler R, Gonzalez de Castro D, Griffiths M, Johnson PWM.
PMID: 30233821
ESMO Open. 2018 Sep 05;3(6):e000408. doi: 10.1136/esmoopen-2018-000408. eCollection 2018.

INTRODUCTION: Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be...

Cite
Lindsay CR, Shaw EC, Blackhall F, et al. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO Open. 2018;3(6):e000408doi: 10.1136/esmoopen-2018-000408.
Lindsay, C. R., Shaw, E. C., Blackhall, F., Blyth, K. G., Brenton, J. D., Chaturvedi, A., Clarke, N., Dick, C., Evans, T. R. J., Hall, G., Hanby, A. M., Harrison, D. J., Johnston, S. R. D., Mason, M. D., Morton, D., Newton-Bishop, J., Nicholson, A. G., Oien, K. A., Popat, S., Rassl, D., Sharpe, R., Taniere, P., Walker, I., Wallace, W. A., West, N. P., Butler, R., Gonzalez de Castro, D., Griffiths, M., & Johnson, P. W. M. (2018). Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO open, 3(6), e000408. https://doi.org/10.1136/esmoopen-2018-000408
Lindsay, Colin R, et al. "Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme." ESMO open vol. 3,6 (2018): e000408. doi: https://doi.org/10.1136/esmoopen-2018-000408
Lindsay CR, Shaw EC, Blackhall F, Blyth KG, Brenton JD, Chaturvedi A, Clarke N, Dick C, Evans TRJ, Hall G, Hanby AM, Harrison DJ, Johnston SRD, Mason MD, Morton D, Newton-Bishop J, Nicholson AG, Oien KA, Popat S, Rassl D, Sharpe R, Taniere P, Walker I, Wallace WA, West NP, Butler R, Gonzalez de Castro D, Griffiths M, Johnson PWM. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO Open. 2018 Sep 05;3(6):e000408. doi: 10.1136/esmoopen-2018-000408. eCollection 2018. PMID: 30233821; PMCID: PMC6135448.
Copy Download .nbib Format: NLM
Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148.

Nature communications

Fang J, Jia J, Makowski M, Xu M, Wang Z, Zhang T, Hoskins JW, Choi J, Han Y, Zhang M, Thomas J, Kovacs M, Collins I, Dzyadyk M, Thompson A, O'Neill M, Das S, Lan Q, Koster R, Stolzenberg-Solomon RS, Kraft P, Wolpin BM, Jansen PWTC, Olson S, McGlynn KA, Kanetsky PA, Chatterjee N, Barrett JH, Dunning AM, Taylor JC, Newton-Bishop JA, Timothy Bishop D, Andresson T, Petersen GM, Amos CI, Iles MM, Nathanson KL, Teresa Landi M, Vermeulen M, Brown KM, Amundadottir LT.
PMID: 29596408
Nat Commun. 2018 Mar 05;9:16159. doi: 10.1038/ncomms16159.

This corrects the article DOI: 10.1038/ncomms15034.

Cite
Fang J, Jia J, Makowski M, et al. Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun. 2018;9:16159doi: 10.1038/ncomms16159.
Fang, J., Jia, J., Makowski, M., Xu, M., Wang, Z., Zhang, T., Hoskins, J. W., Choi, J., Han, Y., Zhang, M., Thomas, J., Kovacs, M., Collins, I., Dzyadyk, M., Thompson, A., O'Neill, M., Das, S., Lan, Q., Koster, R., Stolzenberg-Solomon, R. S., Kraft, P., Wolpin, B. M., Jansen, P. W. T. C., Olson, S., McGlynn, K. A., Kanetsky, P. A., Chatterjee, N., Barrett, J. H., Dunning, A. M., Taylor, J. C., Newton-Bishop, J. A., Timothy Bishop, D., Andresson, T., Petersen, G. M., Amos, C. I., Iles, M. M., Nathanson, K. L., Teresa Landi, M., Vermeulen, M., Brown, K. M., & Amundadottir, L. T. (2018). Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nature communications, 916159. https://doi.org/10.1038/ncomms16159
Fang, Jun, et al. "Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148." Nature communications vol. 9 (2018): 16159. doi: https://doi.org/10.1038/ncomms16159
Fang J, Jia J, Makowski M, Xu M, Wang Z, Zhang T, Hoskins JW, Choi J, Han Y, Zhang M, Thomas J, Kovacs M, Collins I, Dzyadyk M, Thompson A, O'Neill M, Das S, Lan Q, Koster R, Stolzenberg-Solomon RS, Kraft P, Wolpin BM, Jansen PWTC, Olson S, McGlynn KA, Kanetsky PA, Chatterjee N, Barrett JH, Dunning AM, Taylor JC, Newton-Bishop JA, Timothy Bishop D, Andresson T, Petersen GM, Amos CI, Iles MM, Nathanson KL, Teresa Landi M, Vermeulen M, Brown KM, Amundadottir LT. Publisher correction: Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun. 2018 Mar 05;9:16159. doi: 10.1038/ncomms16159. PMID: 29596408; PMCID: PMC6454265.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries